To ask the Scottish Executive how the Healthcare Associated Infection Task Force has fulfilled its remit to monitor levels of hospital-acquired infection and the efficacy of measures taken in general and specifically in relation to Clostridium difficile.
The principal measurements of the levels of healthcare associated infection (HAI) in Scotland have been the long-standing national mandatory and voluntary HAI surveillance schemes, most recently mandated by HDL(2006)38 and the National HAI Point Prevalence Survey carried out by Health Protection Scotland. The mandatory elements of surveillance currently include MRSA bacteraemias, Clostridium difficile and selected surgical site infections. I am pleased to note that MRSA bacteraemias in Scotland have shown a significant decrease since April 2006, and that orthopaedic surgery (hip and knee replacement) and caesarean section infection rates have also declined “ see
http://www.documents.hps.scot.nhs.uk/hai/sshaip/publications/ssi/ssi-2007.pdf.
On 11 July 2007, I announced the publication of the Scottish Point Prevalence Survey which, for the first time, provides us with a comprehensive picture of the rate of HAI in every acute Scottish hospital and in a representative sample of community hospitals. The publication of the survey led to the preparation of a three year HAI Task Force Delivery Plan, which came into affect on 1 April 2008. The Delivery Plan is being backed with £54 million of Scottish Government funding over the next three years and a second Point Prevalence Survey is scheduled for 2011. The delivery plan is available from http://www.scotland.gov.uk/Publications/2008/03/07110818/0.
Mandatory reporting on compliance with hand hygiene and cleaning performance are regularly monitored and reviewed by the HAI Task Force so they remain fit for purpose. I am pleased to note that both these schemes have shown substantial improvements in hand hygiene and cleaning since their implementation, and these are both key areas in the prevention of Clostridium difficile as well as other HAIs.
Another key document relevant to Clostridium difficile is the Scottish Management of Antimicrobial Resistance Action Plan (ScotMARAP), which I launched in March. ScotMARAP outlines the national programme for Scotland in tackling antimicrobial resistance and prudent prescribing over the next five years. The expert Scottish Antimicrobial Prescribing Group (SAPG) has been established to take this forward, and is now starting a programme of work which all the evidence suggests will have a significant effect in prevention of Clostridium difficile infections.
The HAI Task Force has also commissioned extensive staff training resources from NHS Education for Scotland, notably the Cleanliness Champions programme. This programme continues to expand, and has been used in postgraduate and undergraduate training for health professionals here and in other UK countries. In addition, the recently revised NHS Quality Improvement Scotland (NHS QIS) HAI Standards is a key document against which all NHS boards are assessed, both in terms of their organisational structures and practical compliance with HAI policies.
In relation to Clostridium difficile specifically, I refer the member to the announcement I made on 7 August about the publication of both our new National HAI Action Plan and the HAI Action Plan specific to NHS Greater Glasgow and Clyde. Both Action Plans are available from the HAI Task Force website at http://www.scotland.gov.uk/Topics/Health/NHS-Scotland/19529/2005/actionplans.
These additional plans will be fully integrated into our existing national HAI Task Force programme.